Tanja Ilić, PhD

Tanja Ilić was born on February 22, 1986 in Kragujevac. She graduated from the University of Belgrade - Faculty of Pharmacy in 2011 with an average grade 9.68. She obtained her PhD degree in the field of Pharmaceutical Technology in 2019 with PhD thesis entitled “Micro- and nanostructured emulsion systems based on polyhydroxy surfactants for aceclofenac delivery into/through the skin using chemical penetration enhancers and microneedles”. During 2012/2013 she completed an internship in community pharmacies, after which she passed the pharmacist licensing exam. Since October 2012, she worked at Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy as a teaching associate (2012-2014), a junior researcher (2014-2016), a research assistant (2016-2018) and a teaching assistant (2018-2021). In Jun 2021, she became teaching assistant with PhD degree, and currently, she is involved in the realization of the practical part of different courses (Pharmaceutical Technology 1, Pharmaceutical Technology 2, Cosmetology) at the level of integrated academic studies as well as practical course at the specialist academic studies in Cosmetology. Two months during 2015 and 2016, she stayed at the Department of Pharmaceutical Technology of the Eberhard Karls University in Tübingen (Germany). She was involved or is currently involved in 3 national (Program IDEAS, project TR34031 within tehnological development and Proof of Concept program) and 4 international projects (bilateral projects with Germany, JRC Training and Capacity Building Program). She is author/co-author of 24 peer reviewed scientific publications in high ranking international and national journals; 3 chapters in international scientific monographs/books, 4 technical solutions and many presentations at international and national scientific meetings.

Research interest: formulation, physicochemical and in vitro/in vivo characterization of nanostructured systems for skin or brain delivery of poorly water-soluble drugs, development of generic topical drug products and demonstration of their therapeutic equivalence with reference product, efficacy and safety evaluation of dermocosmetic and pharmaceutical products.

• Ilić T, Pantelić I, Savić S. The Implications of Regulatory Framework for Topical Semisolid Drug Products: From Critical Quality and Performance Attributes towards Establishing Bioequivalence. Pharmaceutics. 2021; 13(5):710. doi: 10.3390/pharmaceutics13050710.

• Bubić Pajić N, Vucen S, Ilić T, O'Mahony C, Dobričić V, Savić S. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate. Eur J Pharm Sci. 2021; 164:105895. doi: 10.1016/j.ejps.2021.105895.

• Theochari I, Mitsou E, Nikolic I, Ilic T, Dobrcic V, Plersa V, Savic S, Xenakis A, Papadimitriou V. Colloidal nanodispersions for the topical delivery of Ibuprofen: Structure, dynamics and bioperformances. Journal of Molecular Liquids Journal of Molecular Liquids 2021;334:116021. doi: 10.1016/j.molliq.2021.116021.
• Savić V, Ilić T, Nikolić I, Marković B, Čalija B, Cekić N, Savić S. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment. Int J Pharm. 2019; 569:118624. doi: 10.1016/j.ijpharm.2019.118624.
• Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Technological Approaches for Improving Vaccination Compliance and Coverage. Vaccines (Basel). 2020; 8(2):304. doi: 10.3390/vaccines8020304.
• Ilić T, Savić S, Batinić B, Marković B, Schmidberger M, Lunter D, Savić M, Savić S. Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies. European Journal of Pharmaceutical Sciences 2018; 125: 110–119. doi: 10.1016/j.ejps.2018.09.023.
• Ilić T, Pantelić I, Lunter D, Đorđević S, Marković B, Ranković D, Daniels R, Savić S. Critical quality attributes, in vitro release and correlated in vitro skin permeation-in vivo tape stripping collective data for demonstrating therapeutic (non)equivalence of topical semisolids: A case study of "ready-to-use" vehicles. Int J Pharm. 2017; 528(1-2):253-267. doi: 10.1016/j.ijpharm.2017.06.018.
• Savić V, Todosijević M, Ilić T, Lukić M, Mitsou E, Papadimitriou V, Avramiotis S, Marković B, Cekić N, Savić S. Tacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: Structure characterization and in vitro/in vivo performances. Int J Pharm. 2017; 529(1-2):491-505. doi: 10.1016/j.ijpharm.2017.07.036.
• Đorđević SM, Santrač A, Cekić ND, Marković BD, Divović B, Ilić TM, Savić MM, Savić SD. Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances. Int J Pharm. 2017; 533(2):421-430. doi: 10.1016/j.ijpharm.2017.05.051.
• Isailović T, Ðorđević S, Marković B, Ranđelović D, Cekić N, Lukić M, Pantelić I, Daniels R, Savić S. Biocompatible Nanoemulsions for Improved Aceclofenac Skin Delivery: Formulation Approach Using Combined Mixture-Process Experimental Design. J Pharm Sci. 2016;105(1):308-23. doi: 10.1002/jps.24706.